Tirzepatide vs Semaglutide: Which GLP-1 Is Right for You?
How tirzepatide and semaglutide differ at a high level, the considerations that matter, and how a physician helps choose within the Tampa GLP-1 program.
Published June 7, 2026 · 2 min read
The short answer
Semaglutide acts on the GLP-1 pathway, while tirzepatide acts on two pathways, GLP-1 and GIP. Both reduce appetite and support weight loss under supervision. The right choice depends on your history, response, and how you tolerate each, which is a decision your physician makes with you.
How they differ at a high level
Both medications mimic gut hormones that regulate appetite and blood sugar, which is why patients feel full sooner and eat less. Semaglutide works on the GLP-1 pathway. Tirzepatide works on two pathways, GLP-1 and GIP.
That difference in mechanism is real, but it does not mean one is simply better for everyone. How a given person responds and tolerates each can vary.
Considerations and how a physician helps choose
The practical considerations include your medical history, how you tolerate side effects, your goals, and how your body responds once you start. Both are titrated up slowly to limit digestive side effects, and both work best inside a managed plan rather than on their own.
In our Tampa GLP-1 program, Dr. Rishi Seth helps choose between them and adjusts over time based on labs and response. The program runs on monthly telehealth, quarterly labs, and medication shipped to your home, so the choice is reviewed rather than fixed at the start.